-
"Cylex, Inc., in association with our Korean distributor, Sun Woo Biotech, is delighted to be able to announce our support for a major, multi-center trial of the ImmuKnow assay for cell-mediated immunity at seven highly respected medical institutions in the Republic of Korea," stated Brad Stewart, president of Cylex....
-
Intercell AG (VSE: ICLL) announced that its collaborator Merck & Co., Inc. has initiated a Phase II clinical trial of V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infections. This randomized double blind, placebo controlled study aims to evaluate the safety and immunogenicity of the vaccine ...
-
The Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases announced that new public service announcements (PSAs) targeting the parents of pre-teens are now available to broadcast organizations....
-
WEHI immunologist, Dr Erika Cretney, has been honoured with a L'Oreal Australia For Women in Science Fellowship. Dr Cretney was one of just four Fellowship winners selected by a jury of eminent Australian scientists from a competitive field of 212 nominees. Dr Cretney is studying fascinating cells known in the ...
-
The New England Journal of Medicine on Thursday published two perspective pieces about HIV/AIDS vaccine research and the XVII International AIDS Conference earlier this month in Mexico City. Summaries appear below....
-
WHAT: Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed....
-
XDx, Inc. has received market clearance from the U.S. Food and Drug Administration (FDA) for AlloMap® Molecular Expression Testing. The AlloMap Test is a noninvasive, multi-gene molecular diagnostics blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of ...
-
Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer. Natural Killer (or NK) cells are abundant white blood cells that were recognised over 30 years ago as being able to ...
-
When is the last time you got vaccinated? If you're like most Americans it's been years, maybe even decades. In fact the Centers for Disease Control has warned that far too few American adults are being vaccinated against serious, even deadly diseases. "There's always been an emphasis in pediatrics on ...
-
Most people would agree that stress increases your risk for illness and this is particularly true for severe long-term stresses, such as caring for a family member with a chronic medical illness. However, we still have a relatively limited understanding of exactly how stress contributes to the risk for illness....
-
Novavax, Inc. (NASDAQ: NVAX) announced favorable results from the second stage of the Phase I/IIa human clinical trial of its pandemic influenza virus-like particle (VLP) vaccine candidate. The vaccine, which does not contain an adjuvant, induced robust neutralizing antibody responses. Novavax's VLP candidate is directed against the H5N1 A/Indonesia/05/2005 avian ...
-
Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza....
-
Scientists have long been working to uncover the mystery of what sparks the body's immune system. Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a key component in that puzzle: a new molecule that recognizes a virus infection and initiates the ...
-
Scientists at the University of Pittsburgh Center for Vaccine Research have been awarded $3.6 million from the National Institutes of Health to conduct animal studies of vaccines designed to protect against the most common and deadliest strain of avian flu, H5N1. Recent outbreaks of H5N1 have prompted health officials to ...
-
VaxInnate Corporation announced that its M2e universal influenza vaccine candidate was safe and immunogenic in its first Phase I clinical trial, raising hopes for a universal influenza vaccine that could provide protection against seasonal and pandemic influenza strains....
-
Anadis Limited (ASX: ANX), a research driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses....
-
Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. Gastrointestinal benefits of probiotics have been well-documented, but more and more research is revealing that probiotic benefits extend to the entire body. The report was published in ...
-
Amgen Inc. (NASDAQ: AMGN) announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate™ (romiplostim), the first and only platelet producer for the treatment of thrombocytopenia in splenectomized (spleen removed) and non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP)....
-
Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment (ZAUM) of the Technische Universitat Munchen, scientists at the Helmholtz Zentrum Munchen have pinpointed a major gene for allergic diseases. The gene was localized using cutting edge technologies for examining the whole human ...
-
Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory (CSHL) reported that a particular class of senescent liver cells orchestrates ...
